Japan Coronary Stents Market Report by Type, Biomaterial, Mode of Delivery, End User, and Region 2025-2033

Japan coronary stents market size reached USD 685.0 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 1,026.8 Million by 2033, exhibiting a growth rate (CAGR) of 4.37% during 2025-2033. The growing prevalence of cardiovascular diseases on account of advancing age and lifestyle factors such as unhealthy diets and sedentary lifestyles, is primarily driving the market.

Coronary stents are life-saving medical devices used to treat coronary artery disease (CAD), a common condition where plaque builds up inside the arteries, reducing blood flow to the heart. These small, mesh-like tubes are typically made of metal or biodegradable materials and are inserted into narrowed or blocked coronary arteries during a procedure called angioplasty. Coronary stents serve a crucial role in restoring blood flow to the heart muscle. They work by expanding within the narrowed artery, effectively pushing aside the plaque and creating a wider passage for blood to flow freely. This process not only relieves symptoms like chest pain but also helps prevent heart attacks and other cardiac complications. There are two main types of coronary stents: bare-metal stents and drug-eluting stents. While bare-metal stents are simple and effective, drug-eluting stents are coated with medications that slowly release over time, reducing the risk of re-narrowing the artery. In recent years, advances in stent technology have improved their safety and effectiveness, making them an essential tool in the management of CAD.

Japan Coronary Stents Market Trends:

The coronary stents market in Japan is driven by several key factors. Firstly, the increasing prevalence of cardiovascular diseases, such as CAD, has propelled the demand for coronary stents. Moreover, the aging regional population is a significant driver, as elderly individuals are more susceptible to these ailments. Additionally, advancements in medical technology and the development of innovative stent designs have led to improved treatment outcomes, fostering market growth. Furthermore, the rising awareness about the benefits of minimally invasive procedures and the preference for them among patients has boosted the adoption of coronary stents. Furthermore, favorable reimbursement policies in Japan have incentivized both patients and healthcare providers to opt for stent implantation procedures. Apart from this, the escalating healthcare expenditure, coupled with the increasing disposable income of individuals, has contributed to the expansion of the coronary stents market. Additionally, the ongoing R&D efforts by pharmaceutical and medical device companies to create more efficient and durable stents are expected to drive the coronary stents market in Japan during the forecast period.

Japan Coronary Stents Market Segmentation:

Type Insights:

• Drug-Eluting Stents
• Bare-Metal Coronary Stents
• Bioabsorbable Stents

Biomaterial Insights:

• Metallic Biomaterial
• Polymeric Biomaterial
• Natural Biomaterial

Mode of Delivery Insights:

• Balloon-Expandable Stents
• Self-Expanding Stents

End User Insights:

• Hospitals
• Ambulatory Surgical Centers
• Others

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the key players include:

• Abbott Japan Co. Ltd. (Abbott Laboratories)
• Medtronic Japan Co. Ltd. (Medtronic plc)
• Terumo Corporation

Key Questions Answered in This Report:

• How has the Japan coronary stents market performed so far and how will it perform in the coming years?
• What has been the impact of COVID-19 on the Japan coronary stents market?
• What is the breakup of the Japan coronary stents market on the basis of type?
• What is the breakup of the Japan coronary stents market on the basis of biomaterial?
• What is the breakup of the Japan coronary stents market on the basis of mode of delivery?
• What is the breakup of the Japan coronary stents market on the basis of end user?
• What are the various stages in the value chain of the Japan coronary stents market?
• What are the key driving factors and challenges in the Japan coronary stents?
• What is the structure of the Japan coronary stents market and who are the key players?
• What is the degree of competition in the Japan coronary stents market?